Related Experiment Video
Updated: Jun 21, 2026
07:00
In Ovo Intravascular Injection in Chicken Embryos
Published on: June 3, 2022
The effect of thalidomide in chicken embryos
1Department of Biological Sciences, Idaho State University, Pocatello, Idaho 83209, USA.
Summary
Thalidomide causes limb reduction defects in chick embryos when directly exposed. Specific methods like bead implantation and explant grafting demonstrate this teratogenic effect, with S-enantiomers being more potent.
Area of Science:
- Developmental toxicology
- Teratology
- Embryology
Background:
- Early thalidomide research incorrectly dismissed chick embryos due to flawed experiments.
- Re-evaluation of chick embryos is necessary for understanding thalidomide's teratogenic mechanisms.
Purpose of the Study:
- To investigate the teratogenic effects of thalidomide on chick embryo limb development.
- To establish reliable methods for exposing chick embryos to thalidomide.
Main Methods:
- Direct exposure of chick embryos to thalidomide via soaked bead implantation near limb buds.
- Grafting of thalidomide-soaked limb explants onto host chick embryos.
- Dose-response analysis of thalidomide's teratogenicity.
Main Results:
- Thalidomide exposure directly causes limb reduction defects in chick embryos.
- Implantation and grafting techniques effectively demonstrate thalidomide's teratogenic potential.
- A clear dose-response relationship exists between thalidomide concentration and defect severity.
- Stereoisomers S-thalidomide and S-EM12 exhibited greater teratogenicity than R-enantiomers.
Conclusions:
- Chick embryos are a viable model for studying thalidomide-induced limb malformations.
- Direct exposure and specific surgical techniques are crucial for observing thalidomide's teratogenic effects.
- Enantiomeric specificity plays a significant role in thalidomide's teratogenicity.
